MedTrace Logo

Impact of CPAP Level on V/Q Mismatch in Premature Infants

NCT02983825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-03-25

Study results available
· View outcomes & findings →

Summary

Continuous positive airway pressure (CPAP) is used in premature infants to maintain lungs open and facilitate gas exchange. When ventilation/perfusion (V/Q) mismatch is present, areas of the lung that are open for gas exchange do not match up with the areas of the lung that are receiving blood for gas exchange. This study measure the responsiveness of V/Q mismatch to changes in the amount (or level) of CPAP.

Conditions

  • Infant, Premature, Diseases
  • Respiratory Insufficiency Syndrome of Newborn

Interventions

DEVICE

Continuous positive airway pressure (CPAP); level changes

as per arm description

Sponsors & Collaborators

Principal Investigators

  • Nicolas Bamat, MD, MSCE · University of Pennsylvania

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
24 Hours
Max Age
35 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2019-07-08
Completion
2020-02-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02983825 on ClinicalTrials.gov